Arformoterol tartrate D6
| Product Name | Arformoterol tartrate D6 |
|---|---|
| Alternate Names | Formoterol Stable Isotopes, Stable Isotopes of Formoterol |
| CAT No. | CS-O-15662 |
| CAS No. | 200815-49-2 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Formoterol |
| Therapeutic | Anti-Asthma / COPD |
| Smileys | O[C@@H](C(O)=O)[C@@H](O)C(O)=O.O[C@H](C1=CC(NC=O)=C(O)C=C1)CNC([2H])(C([2H])([2H])[2H])C([2H])([2H])C2=CC=C(OC)C=C2 |
| Canonical Smiles | CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(C(C(=O)O)O)(C(=O)O)O |
| InchIKey | FCSXYHUNDAXDRH-OKMNHOJOSA-N |
| Inchl | InChI=1S/C19H24N2O4.C4H6O6/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-1(3(7)8)2(6)4(9)10/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2,5-6H,(H,7,8)(H,9,10)/t13-,19+;1-,2-/m11/s1 |
| IUPAC | (2R,3R)-2,3-dihydroxybutanedioic acid;N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Arformoterol tartrate D6 is a drug that is used to treat symptoms of chronic obstructive pulmonary disease (COPD) in patients who are experiencing difficulty breathing. It is a selective beta2-adrenergic agonist, which means that it helps to relax the muscles in the airways, allowing the patient to breathe more easily.
The chemical name of Arformoterol tartrate D6 is (R,R)-formoterol tartrate, and it has a molecular formula of C42H56N4O12. It is a white to off-white powder that is soluble in water. The D6 designation indicates that it is a deuterated form of the drug, meaning that six of the hydrogen atoms have been replaced with deuterium atoms.
Arformoterol tartrate D6 is administered via inhalation using a nebulizer or inhaler device. The recommended dosage is typically 15 mcg twice daily, although this may vary depending on the severity of the patient's symptoms and their response to treatment.
As with all medications, there are potential side effects associated with Arformoterol tartrate D6. These may include tremors, headache, nausea, and palpitations. Patients who experience any adverse effects should notify their healthcare provider immediately.
In conclusion, Arformoterol tartrate D6 is a useful medication for treating symptoms of COPD and improving respiratory function. While it is important to be aware of potential side effects, the benefits of this drug can be significant for patients who are struggling with breathing difficulties.
Get an Instant Quote
Related Compounds
Arformoterol D3 | Formoterol d6 Tartarate | Rac Formoterol D6 | Formoterol D6 fumarate | Formoterol D6 | N-Deformyl Formoterol-d6 Fumarate (Mixture of Diastereomers) | Arformoterol 13D3 | N-Methyl Formoterol-d3 Fumarate (Mixture of Diastereomers) |